View in EDS

Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.

Saved in:
Bibliographic Details
Title: Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
Authors: Tomasovic LM; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu K; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., VanDyke D; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA., Fabilane CS; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Program in Molecular Biophysics, Johns Hopkins University, Baltimore, MD, USA., Spangler JB; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Public Health, Baltimore, MD, USA. jamie.spangler@jhu.edu.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2024 Mar; Vol. 38 (2), pp. 227-248. Date of Electronic Publication: 2023 Nov 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37999893
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tomasovic+LM%22">Tomasovic LM</searchLink>; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22VanDyke+D%22">VanDyke D</searchLink>; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fabilane+CS%22">Fabilane CS</searchLink>; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Program in Molecular Biophysics, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Spangler+JB%22">Spangler JB</searchLink>; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Public Health, Baltimore, MD, USA. jamie.spangler@jhu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229705305%22">BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</searchLink> [BioDrugs] 2024 Mar; Vol. 38 (2), pp. 227-248. <i>Date of Electronic Publication: </i>2023 Nov 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9705305 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-190X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211738804%22">11738804 </searchLink><i>NLM ISO Abbreviation: </i>BioDrugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37999893
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40259-023-00635-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 227
    Titles:
      – TitleFull: Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tomasovic LM
      – PersonEntity:
          Name:
            NameFull: Liu K
      – PersonEntity:
          Name:
            NameFull: VanDyke D
      – PersonEntity:
          Name:
            NameFull: Fabilane CS
      – PersonEntity:
          Name:
            NameFull: Spangler JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1179-190X
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
              Type: main
ResultId 1